Amerise Biosciences

Amerise Biosciences Ltd.

BSE: 531681 SECTOR: Finance - Investment  6932   6   1

0.69
+0.01 (1.47%)
BSE: 09 Jun 05:10 PM

Price Summary

Today's High

₹ 0.7

Today's Low

₹ 0.65

52 Week High

₹ 1.3

52 Week Low

₹ 0

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 4.56 Cr.

Advances

₹ 0 Cr.

No. of Shares

6.61 Cr.

P/E

0

P/B

0.83

Face Value

₹ 1

Div. Yield

0 %

Book Value (TTM)

₹  0.84

Operating Revenue

₹ 9.01 Cr.

Net Profit

₹ 0.55 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  -0.02

Sales Growth

0

ROE

10.24 %

ROCE

10.17%

Profit Growth

262.9 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Income Growth

1 Year∞%
3 Year96.9%
5 Year∞%

Profit Growth

1 Year262.9%
3 Year411.15%
5 Year20.91%

ROE%

1 Year10.24%
3 Year0.37%
5 Year0.16%

ROCE %

1 Year10.17%
3 Year0.35%
5 Year0.15%

ROA%

6.23471148436181

PEG Ratio

NA

PAT Margin (%)

6.09642413586868

EPS Growth(%)

262.898939010297

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 0 0
Dec 2022 0 0
Sep 2022 0 0
Jun 2022 0 0
Mar 2022 0 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company is trading at 1.59338281942476 times the book value
  • Operating Income has grown well for the company over past 3 years: 3 years CAGR 96.899786365531%.
  • The company has delivered substantial profit growth of 0% over past 3 years.

 Limitations

  • Promoters shareholding is low at 0%.
  • Company has a poor Return on Equity (ROE) track record of 0.37216324330657%.
  • The company a poor ROCE track record of 0.35165052212808% since last 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
Operating Revenue 6.57 0 0 0 0
Other Income 0 0 0.01 0 0
Interest Expended 0 0 0 0 0
Operating Expenses 6.28 0.04 0.01 0.05 0.02
Total Provisions 0 0 0 0 0
Depreciation 0 0 0 0 0
Profit Before Tax 0.28 -0.04 -0.01 -0.05 -0.02
Tax 0 0 0 0 0
Net Profit 0.29 -0.04 -0.01 -0.05 -0.02

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Operating Income 0 1.18 0 0 9.01
Other Income 0 0 0 0 0.57
Interest 0 0 0 0 0
Operating Expenses 0.02 1.17 0.15 0.11 9.03
Total Provisions 0 0 0 0.23 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.02 0 -0.15 -0.34 0.55
Tax 0 0 0 0 0
Profit After Tax -0.02 0 -0.15 -0.34 0.55
Adjusted EPS (Rs.) 0 0 -0.02 -0.05 0.08

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 6.61 6.61 6.61 6.61 6.61
Total Reserves -1.03 -1.03 -1.18 -1.52 -0.97
Borrowings 0 0 0 0 0.08
Other N/C liabilities 0 0 0 0 0
Current liabilities 0.02 0.02 0.6 0.54 6.27
Total Liabilities 5.6 5.6 6.02 5.63 11.99
Assets
Loans 0 0 0 0 0
Net Block 0 0 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 2.31 0.54 5.37 3.04 4.69
Other Loans 0.57 0.57 0.63 2.57 1.07
Other N/C Assets 0 0 0 0 0
Current Assets 2.72 4.49 0.03 0.02 6.23
Total Assets 5.6 5.6 6.02 5.63 11.99
* Other Non-current Liabilities include Net deferred Liabilities

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 0.00 0.00 0.00 0.00 0.00
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 100.00 100.00 100.00 100.00 100.00

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Amerise Biosciences Stock Price Analysis and Quick Research Report. Is Amerise Biosciences an attractive stock to invest in?

 

Around 2% of India's total population invests in financial assets. The penetration of the mutual fund industry in India is close to 7% (Based on the number of PAN cardholders). This under penetration of the mutual fund industry offers a huge opportunity for the industry to grow. Migration to financial savings, wider distribution and sustainable performance are expected to enable growth in the industry. Also, increasing financial literacy among investors, digitization and the number of mediums available tend to attract more investors to invest in the financial markets.

To understand the functions of the Amerise Biosciences better, you must go through the following points:

Key Financials –

  • Profitability: Profit margin (PAT margin) of the company shows how well a company controls its cost. It is one of the important indicators to show the financial health of the company. Net profit of the company is Rs 0.5491636 Cr and the compounded growth of profit in the past 3 years is 411.143050248772 %. The PAT margin of Amerise Biosciences is 6.09642413586868 %.

  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Amerise Biosciences , the EPS grew by 262.941176470588 % YOY. 

 Financial Ratios –

  •  Return on Equity (ROE): The Company has a average ROE track record. The ROE of Amerise Biosciences is at 10.2367939308267 % for the latest year.

  • P/E Ratio: Relative valuation metrics like the P/E ratio can be used to see if the stock of Amerise Biosciences is worth at the current levels at Rs 0.69. The stock is trading at a current P/E ratio of 16.3619438724635 and the average historical P/E for the last 5 years was 3.27316486161252.

  • P/B ratio can be one of the best metrics to value such companies. Currently, Amerise Biosciences is trading at a P/B of 0.8139 . The average historical P/B for the last 5 years was 0.946670232508299. This can be compared with the Market price per share in order to know if the stock is undervalued or overvalued.

Brief about Amerise Biosciences

X